新生儿心血管治疗
Cardiovascular therapy in the newborn.
作者信息
Sandor G G
出版信息
Clin Invest Med. 1985;8(4):360-7.
PMID:3907921
Abstract
Considerations for the use of the principal inotropic agents (digoxin and dopamine) in the newborn are discussed. The role of Prostaglandin-E in retaining the patency of the ductus arteriosus in the initial treatment of anomalous vessel formation is outlined. Conversely, chemotherapeutic possibilities for inhibiting prostaglandin production and thus encouraging closure of the ducts prior to surgical intervention are described.
摘要
讨论了新生儿使用主要强心剂（地高辛和多巴胺）的注意事项。概述了前列腺素E在异常血管形成初始治疗中维持动脉导管通畅的作用。相反，描述了在手术干预前抑制前列腺素产生从而促进导管闭合的化疗可能性。
相似文献
1
Cardiovascular therapy in the newborn.新生儿心血管治疗
Clin Invest Med. 1985;8(4):360-7.
2
Prostaglandins and the management of congenital heart disease.前列腺素与先天性心脏病的治疗
Am Fam Physician. 1982 Dec;26(6):127-32.
3
Pharmacological manipulation of the ductus arteriosus.动脉导管的药物调控
Arch Dis Child. 1986 Sep;61(9):827-9. doi: 10.1136/adc.61.9.827.
4
Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.前列腺素及前列腺素合成酶抑制剂在新生儿心脏问题中的临床应用。
Adv Prostaglandin Thromboxane Res. 1980;7:913-6.
5
The ductus arteriosus: why and how to manipulate its patency.动脉导管：为何以及如何控制其通畅性。
J Fla Med Assoc. 1983 Sep;70(9):788-93.
6
Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.关于新生儿动脉导管药物调控的评论
Adv Prostaglandin Thromboxane Res. 1978;4:383-5.
7
Medical treatment of the ductus arteriosus.动脉导管的医学治疗。
Hosp Pract. 1977 Feb;12(2):57-65. doi: 10.1080/21548331.1977.11707078.
8
[Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
Orv Hetil. 1980 May 18;121(20):1197-9.
9
[Prostaglandin treatment of ductus-dependent congenital heart defects].[前列腺素治疗依赖动脉导管的先天性心脏缺陷]
Lakartidningen. 1984 Oct 3;81(40):3619-22.
Zotero 插件